Related Experiment Video
Updated: Oct 9, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Recent Discoveries in Epigenetic Modifications of Polycystic Kidney Disease
Sarah A Bowden1, Euan J Rodger1,2, Aniruddha Chatterjee1,2
1Department of Pathology, Dunedin School of Medicine, University of Otago, 270 Great King Street, Dunedin 9054, New Zealand.
Abstract:
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a heritable renal disease that results in end-stage kidney disease, due to the uncontrolled bilateral growth of cysts throughout the kidneys. While it is known that a mutation within a PKD-causing gene is required for the development of ADPKD, the underlying mechanism(s) causing cystogenesis and progression of the disease are not well understood. Limited therapeutic options are currently available to slow the rate of cystic growth. Epigenetic modifications, including DNA methylation, are known to be altered in neoplasia, and several FDA-approved therapeutics target these disease-specific changes. As there are many similarities between ADPKD and neoplasia, we (and others) have postulated that ADPKD kidneys contain alterations to their epigenetic landscape that could be exploited for future therapeutic discovery. Here we summarise the current understanding of epigenetic changes that are associated with ADPKD, with a particular focus on the burgeoning field of ADPKD-specific alterations in DNA methylation.
Insights
Autosomal Dominant Polycystic Kidney Disease (ADPKD) involves kidney cyst growth. Research suggests epigenetic changes, particularly DNA methylation, may offer new therapeutic targets for this genetic kidney disorder.
Area of Science:
- Nephrology
- Genetics
- Epigenetics
Background:
- Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a genetic disorder characterized by kidney cyst development, often leading to end-stage renal disease.
- The precise mechanisms driving cystogenesis and disease progression in ADPKD remain incompletely understood.
- Current therapeutic strategies for ADPKD are limited in their ability to slow cystic growth.
Purpose of the Study:
- To review the current understanding of epigenetic alterations in ADPKD.
- To highlight the role of DNA methylation in ADPKD pathogenesis.
- To explore the potential of epigenetic modifications as therapeutic targets for ADPKD.
Main Methods:
- Literature review of studies investigating epigenetic changes in ADPKD.
- Focus on research examining DNA methylation patterns in ADPKD kidneys.
- Analysis of similarities between ADPKD and neoplasia regarding epigenetic landscapes.
Main Results:
- Epigenetic modifications, such as DNA methylation, are altered in various diseases, including neoplasia.
- Similarities exist between ADPKD and neoplastic conditions, suggesting potential epigenetic dysregulation in ADPKD.
- Emerging evidence points to specific alterations in DNA methylation within ADPKD kidneys.
Conclusions:
- Epigenetic alterations, particularly DNA methylation changes, are implicated in ADPKD.
- The epigenetic landscape of ADPKD kidneys presents potential targets for novel therapeutic interventions.
- Further research into ADPKD-specific epigenetic modifications could lead to new treatment strategies.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Epigenetic Regulation
X-chromosome...
Nephrons
Chronic Kidney Disease III: Interprofessional Care

